Massachusetts H2502 clarifies the state's prescription monitoring program by excluding testosterone from the list of monitored drugs.
Massachusetts H2502 amends the state's prescription monitoring program by excluding testosterone from the list of drugs tracked in the system. This change aims to refine the monitoring process, focusing on other substances while exempting testosterone. The bill mandates the immediate removal of any existing testosterone data from the monitoring system upon enactment. This legislative action seeks to streamline the monitoring efforts and potentially reduce unnecessary surveillance on testosterone prescriptions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.